Physician profile
Daniel A Talley
NPI 1285621896
$480.48
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $17.60 · 2021: $70.37 · 2022: $33.37 · 2024: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $152 · Food and Beverage: $77.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $151.67 |
| Food and Beverage | $77.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $173.78 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $67.56 | 2019 | |
| Glaukos Corporation | $55.82 | 2021 | |
| Bausch & Lomb Americas INC. | $55.17 | 2024 | Infuse |
| Lombart Brothers, INC. | $37.03 | 2019 | |
| Alcon Vision LLC | $33.37 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $32.13 | 2019-2020 | |
| Coopervision INC. | $14.55 | 2021 | |
| Shire North American Group INC | $11.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Talley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.